Wells Fargo analyst Michael Turrin raised the firm’s price target on DocuSign (DOCU) to $67 from $65 and keeps an Underweight rating on the shares. The firm notes the company’s Q1 showed a bit of mean reversion after a few quarters of improving growth, with billings +4% and FY26 CC billings outlook lower. Key debate going forward is tied to emerging IAM product story and potential uplift, Wells says.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign’s Strategic Shift and Macroeconomic Challenges Lead to Hold Rating
- DocuSign: Strong Fundamentals and Growing IAM Demand Justify Buy Rating Despite Billing Challenges
- Docusign Reports Strong Q1 Fiscal 2026 Results
- Closing Bell Movers: Lululemon falls over 20% on soft guidance
- DocuSign down 14% to $79.52 after Q1 results, FY26 guidance